Hui Cai
Corporate Officer/Principal bij WUXI APPTEC CO., LTD.
Profiel
Hui Cai is currently the VP-Corporate Alliances & Communications at WuXi AppTec Co., Ltd.
Prior to this, Dr. Cai held the position of Vice President-Corporate Development at HUYA Bioscience International LLC and President at Inflexion BioPartners, Inc. Dr. Cai's education includes a doctorate from The Scripps Research Institute, undergraduate and graduate degrees from Peking University, and an MBA from the University of California San Diego.
Actieve functies van Hui Cai
Bedrijven | Functie | Begin |
---|---|---|
WUXI APPTEC CO., LTD. | Corporate Officer/Principal | - |
Eerdere bekende functies van Hui Cai
Bedrijven | Functie | Einde |
---|---|---|
Inflexion BioPartners, Inc. | President | - |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Opleiding van Hui Cai
The Scripps Research Institute | Doctorate Degree |
Peking University | Graduate Degree |
University of California San Diego | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
WUXI APPTEC CO., LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Inflexion BioPartners, Inc. |